Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 84

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 84
---
 terms of the Seller Note and, accordingly, it began accruing additional interest of 5.0% in addition to the 12.0% initial rate, as of the date of the default. As of December 31, 2024, the Seller Note had outstanding accrued interest of $0. This Seller Note was settled in 2024 for a cash payment of $2.2 million.Convertible promissory notes payable, related party - In August 2020, the Company issued a convertible promissory note payable in the amount of $1.4 million. The note matured on August 6, 2021, and was not repaid and thus was in default. As of December 31, 2024, the note had outstanding accrued interest of $0.The convertible promissory note was settled in 2024 for a cash payment of $1.4 million, which resulted in a gain on the extinguishment of debt of $0.8 million and a reduction in accrued interest of $0.8 million.

12.        Revenue

The disaggregation of revenue is based on type and geographical region. The following table presents revenue from contracts with customers:Three Months Ended June 30, 2025Three Months Ended June 30, 2024United StatesInternationalTotalUnited StatesInternationalTotalConsumables and parts revenue$6,686 $6 $6,692 $4,920 $31 $4,951 System revenue3,445 - 3,445 2,112 - 2,112 License fees and other- 10 10 - 15 15 Product Revenue$10,131 $16 $10,147 $7,032 $46 $7,078 Rental Income17 - 17 84 - 84 Total Revenue$10,148 $16 $10,164 $7,116 $46 $7,162 Six Months Ended June 30, 2025Six Months Ended June 30, 2024United StatesInternationalTotalUnited StatesInternationalTotalConsumables and parts revenue$12,764 $16 $12,780 $9,161 $97 $9,258 System revenue6,643 - 6,643 3,413 71 3,484 License fees and other- 15 15 - 20 20 Product Revenue